Explore the complete record of transactions filed by 김상재, Dirigeant. Insider active across 1 companies, notably 젬백스. In total, 12 reports have been published. The latest transaction was filed on 13 May 2026 — Purchase. Regulator: DART (FSS). The full history is openly available.
Kim Sang-jae is an executive at GemVax, a company specializing in biotechnology. He contributes to the management and strategy of the company, aiming to innovate in the healthcare sector.